News
Catch up on our latest press releases, corporate updates and announcements.
Press Releases
ALL
2022
Structure Therapeutics Extends Financing, Advances Diabetes and Obesity Clinical Program and Changes Name from ShouTi
/in 2022, Press Releases/by eallisonShouTi Introduces Basecamp Bio as a Wholly Owned Subsidiary to Expand Pipeline and Partnerships
/in 2022, Press Releases/by Emily HennesShouTi Strengthens Board with Appointment of Daniel G. Welch as Chairman
/in 2022, Press Releases/by Emily Hennes2021
ShouTi Secures $100 Million Series B Financing to Accelerate Development of Life-Changing Medicines Fueled by Advanced Computational, Structure-Based Drug Design Platform
/in 2021, Press Releases/by Emily HennesIn the Media
BioSpace: ShouTi’s Rationally Designed Small Molecules are Challenging Biologics and Peptides
https://www.biospace.com/article/shouti-s-rationally-designe…
Wall Street Journal: VC Daily: ShouTi Lands $100 Million to Develop Pills for Chronic Diseases
https://www.wsj.com/articles/vc-daily-shouti-lands-100-milli…
FierceBiotech: Receptos founder returns with ShouTi and $100M for oral drugs to treat chronic diseases
https://www.fiercebiotech.com/biotech/receptos-founder-retur…
Endpoints News: A new Schrödinger-backed startup emerges from the scientist who mapped the first human GPCR
https://endpts.com/a-new-schrodinger-backed-startup-emerges-…
Structure Therapeutics CEO Raymond Stevens Named to PharmaVoice 100
/in 2022, Press Releases/by Andrea KushnerStructure Therapeutics Extends Financing, Advances Diabetes and Obesity Clinical Program and Changes Name from ShouTi
/in 2022, Press Releases/by eallisonShouTi Appoints Sharon Tetlow to Board of Directors
/in 2022, Press Releases/by Andrea KushnerShouTi Introduces Basecamp Bio as a Wholly Owned Subsidiary to Expand Pipeline and Partnerships
/in 2022, Press Releases/by Emily HennesShouTi Strengthens Board with Appointment of Daniel G. Welch as Chairman
/in 2022, Press Releases/by Emily HennesShouTi Secures $100 Million Series B Financing to Accelerate Development of Life-Changing Medicines Fueled by Advanced Computational, Structure-Based Drug Design Platform
/in 2021, Press Releases/by Emily Hennes